HAS3 and breast cancer: Treatment of breast cancer cells Hs578T with DDIT induced the mRNA expression of hyaluronan synthases HAS1 and HAS3 more than 2-fold, and the HAS2 transcript to a much lesser degree, while 4-MU had no effect (Figure 6A).